Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 88, pseudogene (RNU1-88P) is a human genomic locus annotated as a pseudogene of the U1 small nuclear RNA gene family. Unlike canonical U1 small nuclear RNAs, which play essential roles in pre-mRNA splicing as core components of the spliceosome, pseudogenes such as RNU1-88P generally lack evidence of functional RNA products, protein expression, or direct involvement in biological processes[1][3][4][6]. There is no experimental data supporting its role as a therapeutic target, as a biomarker, or as a mediator of disease. Its annotation as a "pseudogene" indicates it is considered a nonfunctional genomic sequence resulting from duplication or retrotransposition events and does not encode an active gene product[1][3]. Key context: - RNU1-88P should not be confused with functional U1 snRNA genes (such as RNU1-1); these encode critical components of the spliceosome involved in RNA splicing and have established biological functions[2][5][7]. - There is no known disease association, no interacting drugs, and it is not established as a receptor, enzyme, or other classical therapeutic target[1][3][4]. - As a pseudogene, its clinical or biological relevance is limited, and it is not considered a therapeutic or diagnostic target[1][3]. Summary: RNU1-88P is a non-protein-coding pseudogene with no confirmed biological or disease function, and should not be treated as a molecular therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 88, pseudogene (RNU1-88P).